Study on SARS-CoV-2 Reinfection Risks

The study, titled “Acute and postacute sequelae associated with SARS-CoV-2 reinfection” used the U.S. Department of Veterans Affairs’ healthcare database. It included 443,588 individuals with one COVID-19 infection, 40,947 with reinfections, and a control group of 5,334,729 non-infected individuals​​. Key Findings Implications Study Limitations Conclusion The study provides compelling evidence that SARS-CoV-2 reinfection carries additional health risks, including increased mortality and a broad range of sequelae, reinforcing the importance of infection and reinfection prevention in public health policy. Read More: